Project Grant R43EB036391
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $306,463 Project Grant under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program to Dogpatch Medical LLC, effective September 1, 2025 through August 31, 2026. The grant funding supports the development of PASSIVECATH, an innovative microcatheter device designed for enhanced visibility and targeted drug delivery to the central nervous system...
- This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), is focused on developing a next-generation photoacoustic computed tomography device for non-invasive monitoring of brain oxygen metabolism. The $249,000 award, spanning July 2025 to June 2028, aims to design, fabricate, and validate a handheld photoacoustic imaging device that...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $514,357 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the Massachusetts Institute of Technology (MIT) on June 1, 2025. The purpose of this grant is to support the development and prototype demonstration of a portable, liquid-helium-free 1-T/560-mm RT bore point-of-care MRI magnet. This innovative MRI technology is intended to...
- This $306,509 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Captis Diagnostics Inc. aims to develop a technology platform for rapid magnetic isolation of neuronal extracellular vesicles (EVs) from blood plasma samples. The goal is to enable the detection of biomarkers for neurological diseases such as Alzheimer's, Parkinson's, and traumatic brain injury through a minimally invasive liquid biopsy approach. Key activities include developing...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $263,749 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Sound Innovation LLC in Albany, NY. The grant supports the development of a portable small animal imager to accelerate drug development. The project aims to create a cost-effective and high-quality imaging solution to improve the preclinical stage of the drug development...
- This federal Project Grant award of $422,623.00, provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), supports the development of a high-fidelity brain perfusion MRI technique for newborns less than one week of age. The project, led by The Johns Hopkins University, aims to address the critical challenge of measuring cerebral blood flow...
- The National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) awarded Cordance Medical Inc. a $999,125 Project Grant on September 11, 2025 to develop the "NeuroAccess" system, a focused ultrasound device designed for safe, temporary, and non-invasive blood-brain barrier (BBB) opening. This technology enables a novel liquid biopsy technique called "sonobiopsy" to improve the clinical management of malignant brain tumor patients by providing timely...
- This Project Grant award, funded by the National Science Foundation's Engineering program (CFDA 47.041), supports the development of a novel non-surgical bioelectronic brain implant technology. The $599,918 award to the Massachusetts Institute of Technology (MIT) aims to create intravenously-introduced bioelectronic devices that can autonomously implant in target brain regions without the need for invasive surgery. The proposed technology promises to enable high-resolution brain stimulation...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded a $306,203 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Resonance Research Inc. The grant, awarded on September 1, 2024, supports the development of an advanced, digitally-controlled multiband shimming system for improved neuroimaging using high-field magnetic resonance imaging (MRI) scanners. The goal is to create a...
- The National Science Foundation awarded a $266,000 Project Grant to Columbia University under the NSF Technology, Innovation, and Partnerships federal grant program (CFDA 47.084) to develop a wearable noninvasive brain imaging device using near-infrared light-based time-domain diffuse optical tomography. The device aims to improve clinical outcomes in neurology by enabling measurement of deep brain blood flow, which is difficult to measure with current technologies. The grant will support...
The U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $349,908 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Evanesc Therapeutics, Inc. to develop a non-invasive medical device designated "EvaPERMEA" that uses low-power radio frequency evanescent waves to temporarily permeabilize the blood-brain barrier. This innovation aims to improve the delivery of therapeutic agents to the brain for the treatment of central nervous system diseases like Alzheimer's, Parkinson's, and brain cancers. The EvaPERMEA device is designed to be low-cost, patient-friendly, and usable in a non-clinical setting, in contrast to existing approaches that require invasive procedures or specialized facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $349.9k | 8/26/25 |